STOCK TITAN
  1. Home
  2. Sec-filings
  3. NSPR
  4. [Form 4] InspireMD, Inc. Insider Trading Activity

InspireMD, Inc. (NSPR) director gets 88,053-share restricted stock award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

InspireMD, Inc. director Michael Berman reported an equity grant of common stock. On January 14, 2026, he received 88,053 shares of restricted common stock at a price of $0 per share, increasing his directly held beneficial ownership to 352,586 common shares.

The filing explains that these 88,053 shares are restricted stock that will vest on January 14, 2027, as long as he continues in service through that date. It also lists an additional 244,994 common shares as indirectly held through the Michael Berman Revocable Trust, with no transaction in those trust-held securities; they are included for informational reporting only.

Positive

  • None.

Negative

  • None.
Insider BERMAN MICHAEL
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 88,053 $0.00 --
holding Common Stock -- -- --
Holdings After Transaction: Common Stock — 352,586 shares (Direct); Common Stock — 244,994 shares (Indirect, See Footnote)
Footnotes (1)
  1. These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
BERMAN MICHAEL
(Last) (First) (Middle)
C/O INSPIREMD, INC.
6303 WATERFORD DISTRICT DRIVE, SUITE 215
(Street)
MIAMI FL 33126
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
InspireMD, Inc. [ NSPR ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
01/14/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 01/14/2026 A 88,053(1) A $0 352,586 D
Common Stock 244,994 I See Footnote(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. These shares of common stock represent shares of restricted stock that shall vest on January 14, 2027 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.
2. These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
Remarks:
Exhibit 24.1: Power of Attorney
/s/ Michael Lawless, Attorney-in-Fact for Michael Berman 01/16/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did InspireMD (NSPR) report for Michael Berman?

The filing reports that director Michael Berman received an award of 88,053 shares of restricted InspireMD common stock on January 14, 2026, at a price of $0 per share.

How many InspireMD shares does Michael Berman beneficially own after this Form 4?

After the reported grant, Michael Berman beneficially owns 352,586 shares of InspireMD common stock directly, according to the Form 4.

When do Michael Berman’s newly granted InspireMD restricted shares vest?

The 88,053 restricted shares are scheduled to vest on January 14, 2027, provided Michael Berman continues in service through that date.

What is the significance of the Michael Berman Revocable Trust in this InspireMD Form 4?

The Form 4 notes 244,994 shares of InspireMD common stock held by the Michael Berman Revocable Trust. The filing states no transaction was effected in these securities; they are reported for informational purposes as indirect holdings.

Was there any sale of InspireMD shares reported in this Form 4?

No sales are shown. The reported activity is an acquisition (code "A") of 88,053 restricted shares at $0 per share, reflecting an equity award rather than an open-market purchase or sale.

What role does Michael Berman have at InspireMD (NSPR)?

The Form 4 identifies Michael Berman as a director of InspireMD, Inc., and the reported equity grant relates to his service in that role.